I dunno about expecing it. But I believe it is a pohsibility....

I dunno about expecing it. But I believe it is a pohsibility. They cant buy on market without shifting the sp much much higher. I doubt the key investprs are likely to sell for very little.

If there was a cap raising they wouldnt get such a stake.

So if you were Novartis or CSL and can see first hand what the tech can do and what cash flows it can generate for so many products for many many years to come $50 mill would be a bargain and pocket change. It would also underpin the sp at what they paid for it and increase tje sp beyond that due to $ uncertainty being completly removed.

CSL have heaps of cash. Growth prospects are tight at the moment. Mcnamee is very clever. IF the vaccine TPM trials are proving their worth it could make them the leader in a $25+ billion dollar vaccine market. And 20+% of the pharma pipelines etc .

For $50 mill they reap the benefits in all directions.

Novartis pet diabetes leads to human diabetes, possible voltaren TPM gels and patches. Tje fit is good and pocket change